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Abstract
Introduction: Invasive ductal and lobular carcinomas represent 67.9% and 6.3% of breast
carcinoma, respectively. Metastatic breast cancer typically involves the lungs, bones, brain, and liver.
Studies have shown differing patterns of metastatic spread between ductal and lobular carcinoma.
Lobular carcinoma is more likely to metastasise to the gastrointestinal tract.
Case presentation: We report the case of a 49 year old white woman with invasive ductal
carcinoma with lobular differentiation who developed submucosal oropharyngeal metastases nearly
two years after her original diagnosis after presenting with odynophagia and dysphagia. The
patient's symptoms preceded any associated radiological or endoscopic abnormalities by at least 9
months. Repeat computed tomography scan and eventual oropharyngeal biopsy confirmed
submucosal metastatic invasive ductal carcinoma, suggesting occult submucosal spread.
Conclusion: This case illustrates the importance of maintaining a high index of suspicion for
metastatic disease in patients with invasive breast cancer who present with unusual symptoms and
a careful search for metastatic sites.
Introduction
Invasive ductal and lobular carcinomas represent 67.9%
and 6.3% of breast carcinoma, respectively [1]. Metastatic
breast cancer typically involves the lungs, bones, brain,
and liver [2]. Studies have shown differing patterns of
metastatic spread between ductal and lobular carcinoma
[3]. Borst and Ingold [4] reported a significantly higher
prevalence of metastatic lobular cancer to the gastrointes-
tinal (GI) tract, peritoneum and retroperitoneum, and
gynaecological organs, than metastatic ductal cancer. The
most common sites of gastrointestinal involvement are
the stomach and colon [4].
Case presentation
A 49 year old white woman was diagnosed in August 2005
with a grade 2 invasive mixed ductal and lobular carci-
noma of the left breast (oestrogen receptor negative, pro-
gesterone receptor negative, HER2 receptor negative) with
left supraclavicular lymphadenopathy, but no axillary
lymphadenopathy.
The patient received 6 cycles of neoadjuvant epirubicin,
cyclophosphamide and 5-fluorouracil (FEC) chemother-
apy with good response. In February 2006 she was found
to have two enlarged right supraclavicular lymph nodes.
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proceeded to weekly paclitaxel chemotherapy, receiving 6
cycles before progressing with new nodes in both supra-
clavicular fossae and left cervical lymph nodes and diffi-
culty swallowing. The patient also complained of
discomfort in the anterior neck. Both radiological and
ultrasonographic examinations were normal.
The patient received radiotherapy to the left breast, axilla
and left supraclavicular fossa (40 Gray in fifteen fractions
to the left breast and 50 Gray in twenty-five fractions to
the left axilla and supraclavicular fossa) followed by gem-
citabine and carboplatin chemotherapy with good
response – staging computed tomography (CT) scan
showed good response to chemotherapy with no signifi-
cantly enlarged lymph nodes.
In view of ongoing dysphagia/odynophagia and the ear-
lier presentation with supraclavicular lymphadenopathy,
the patient underwent endoscopy which revealed mild
gastritis. She completed a ten day course of oral flucona-
zole and was prescribed maintenance proton pump inhib-
itor. CT scans were repeated 7 months later due to
persistent symptoms of odynophagia. This scan con-
firmed stable disease with some generalised thickening of
the oesophagus in the subcarinal region in relation to
small volume adenopathy; however, this was unchanged
compared to previous imaging. Barium swallow showed
no hold-up, stricturing or dysmotility. There was no
mucosal abnormality with no evidence of a cricoid web.
This was confirmed on repeat endoscopy.
As a result of ongoing odynophagia, a repeat CT scan was
requested at a further 2 month interval (nine months after
the onset of symptoms) which revealed a new lesion in
the oropharynx [fig 1] and significant adenopathy within
the neck (cervical and supraclavicular lymph nodes),
more marked on the left than right. There was also note
made of some soft tissue thickening in the prevertebral
space below the level of the larynx and circumferential
thickening of the cervical and proximal thoracic oesopha-
gus with no discrete mass. Fibre-optic nasendoscopy
revealed no asymmetry of the oropharynx. Subsequent
examination under anaesthetic and biopsy of the area
confirmed submucosal metastatic invasive ductal carci-
noma with some lobular differentiation [fig 2]. E-Cad-
herin staining showed strong expression within the
majority of the tumour cells [fig 3]. E-Cadherin stain was
then performed on the original biopsy and showed strong
expression, supporting the diagnosis of an original ductal
carcinoma with lobular features, rather than a pure lobu-
lar carcinoma.
The patient had a radiologically-inserted gastrostomy
tube inserted for feeding and commenced palliative radi-
otherapy to the neck to cover the oropharyngeal disease
but her disease progressed during treatment with airway
narrowing and stridor. The patient is currently being pal-
liated at home.
Discussion
Breast cancer metastases to the gastrointestinal tract (GIT)
is rare, and is more frequently a feature of lobular infiltrat-
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by lymphatics to the oesophagus typically results in stric-
ture formation or submucosal formation of the metastatic
tumour mass with normal overlying mucosa, thereby
making endoscopic diagnosis difficult [6-8]. The patient's
symptoms preceded any associated radiological or endo-
scopic abnormalities by at least 9 months suggesting
occult submucosal spread. The absence of stricturing on
barium study is an unusual feature of this case. In addi-
tion, oropharyngeal spread is less reported. In a recent
review of the literature by Nazareno et al [9] one case of
oropharyngeal metastasis was described and this was a
discrete mass in the post cricoid region rather than sub-
mucosal spread as illustrated in this case. Raut et al [10]
described a case of metastatic adenocarcinoma of the
breast as a discrete mass in the parapharyngeal space, fif-
teen years after the primary diagnosis. Just et al [11] report
a case of a woman with breast cancer who developed pap-
illomatosis and acanthosis of the oral cavity prior to the
patient developing metastatic disease of the liver, which
was followed by regression of the oral lesions after treat-
ment of the liver metastases, in keeping with a paraneo-
plastic phenomenon.
About 50% of all metastatic disease of the oesophagus
present with dysphagia [12] and metastatic breast carci-
noma has been estimated to account for 0.4% of all cases
of symptomatic oesophageal obstruction [13]. The onset
of dysphagia secondary to oesophageal metastasis from
primary diagnosis is typically long, with a mean time of
mastectomy to the onset of dysphagia of 7.1 +/- 4.2 years
with a peak incidence of 4 to 5 years [14].
The reason for these differences in the metastatic patterns
of lobular carcinoma and infiltrating ductal carcinoma is
unknown. Invasive ductal carcinoma (IDC) and invasive
lobular carcinoma (ILC) have distinct histological pat-
terns. IDC are composed of cells arranged in well formed
glandular structures, whereas ILC correspond to a prolifer-
ation of non-cohesive small cells dispersed in a fibrous
stroma [15]. It has been suggested that loss of expression
of the cell-cell adhesion molecule E-cadherin in infiltrat-
ing lobular carcinoma could result in the non-cohesive
tumour cells and this may play a part in the differing pat-
tern of local and metastatic tumour progression [16].
Down-regulation of E-cadherin may facilitate cell spread-
ing and/or cell growth, resulting in tumour growth and
dissemination. It is therefore even more unusual that met-
astatic spread to uncommon sites should occur in patients
with ductal carcinoma.
Conclusion
This case illustrates the importance of maintaining a high
index of suspicion for metastatic disease in patients with
invasive breast cancer who present with unusual symp-
toms and a careful search for metastatic sites, even in
those patients with ductal carcinoma. In this case, earlier
imaging with a positron-emission tomography scan (PET
scan) may have been useful, but would not have relin-
quished the need for endoscopy and tissue biopsy to con-
firm the diagnosis.
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